Clinical and Genetic Characteristics of Multiple Epiphyseal Dysplasia Type 4.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
24 08 2022
Historique:
received: 24 07 2022
revised: 16 08 2022
accepted: 19 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Multiple epiphyseal dysplasias (MED) are a clinically and genetically heterogeneous group of skeletal dysplasias with a predominant lesion in the epiphyses of tubular bones. Variants in the SLC26A2 gene cause their autosomal recessive form (rMED or MED type 4). The accumulation of data regarding the genotype−phenotype correlation can help in the diagnosis and proper management of these patients. The aim of this study was to survey the clinical and genetic characteristics of 55 patients with MED type 4 caused by variants in the SLC26A2 gene. Diagnosis confirmation was carried out by radiography and custom panel sequencing consisting of 166 genes responsible for the development of hereditary skeletal pathology. This was followed by the validation of the identified variants using automated Sanger sequencing (for six patients) and the direct automatic Sanger sequencing of the coding sequence and the adjacent intron regions of the SLC26A2 gene for 49 patients. Based on the clinical and genetic analysis of our sample of patients, two main MED type 4 phenotypes with early and late clinical manifestations were identified. An early and more severe form of the disease was observed in patients with the c.835C > T variant (p.Arg279Trp), and the late and milder form of the disease was observed in patients with the c.1957T > A variant (p.Cys653Ser) in the homozygous or compound heterozygous state with c.26 + 2T > C. It was also shown that only three pathogenic variants were found in 95.3% of the alleles of Russian patients with MED type 4: c.1957T > A (p.Cys653Ser), c.835C > T (p.Arg279Trp), and c.26 + 2T > C; thus, it can be assumed that the primary analysis of these variants will contribute to the optimal molecular genetic diagnostics of MED type 4.

Identifiants

pubmed: 36140680
pii: genes13091512
doi: 10.3390/genes13091512
pmc: PMC9498659
pii:
doi:

Substances chimiques

Anion Transport Proteins 0
SLC26A2 protein, human 0
Sulfate Transporters 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Mol Genet Genomic Med. 2021 Apr;9(4):e1630
pubmed: 33724725
Am J Med Genet A. 2003 Oct 15;122A(3):187-92
pubmed: 12966518
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Arch Pathol Lab Med. 2001 Oct;125(10):1375-8
pubmed: 11570921
Am J Med Genet A. 2010 Dec;152A(12):3036-42
pubmed: 21077204
Genes (Basel). 2021 May 11;12(5):
pubmed: 34064542
Matrix Biol. 1998 Oct;17(5):361-9
pubmed: 9822202
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Proc R Soc Med. 1946 Apr;39(6):315-7
pubmed: 19993290
Australas Radiol. 2000 Nov;44(4):450-3
pubmed: 11103546
Best Pract Res Clin Rheumatol. 2008 Mar;22(1):19-32
pubmed: 18328978
J Med Genet. 2003 Jan;40(1):65-71
pubmed: 12525546
Hum Mol Genet. 2001 Jul 1;10(14):1485-90
pubmed: 11448940
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Med Genet. 1999 Aug;36(8):621-4
pubmed: 10465113
Clin Genet. 2011 Dec;80(6):550-7
pubmed: 21155763
Ann N Y Acad Sci. 1996 Jun 8;785:195-201
pubmed: 8702127
Orthop Surg. 2014 Nov;6(4):274-9
pubmed: 25430710
BMC Musculoskelet Disord. 2010 Jun 03;11:110
pubmed: 20525296
Hum Mol Genet. 2004 Oct 1;13(19):2165-71
pubmed: 15294877
J Med Genet. 2001 Mar;38(3):191-3
pubmed: 11303514
Clin Genet. 1999 Jul;56(1):71-6
pubmed: 10466420
Eur J Med Genet. 2019 Nov;62(11):103573
pubmed: 30423444
Nature. 2013 Jan 10;493(7431):216-20
pubmed: 23201682
J Biol Chem. 1998 May 15;273(20):12307-15
pubmed: 9575183
J Hum Genet. 2008;53(8):764-768
pubmed: 18553123

Auteurs

Tatiana Markova (T)

Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.

Vladimir Kenis (V)

H. Turner National Medical Research Center for Children's Orthopedics and Trauma Surgery, Parkovaya 64-68, 196603 Saint Petersburg, Russia.

Evgenii Melchenko (E)

H. Turner National Medical Research Center for Children's Orthopedics and Trauma Surgery, Parkovaya 64-68, 196603 Saint Petersburg, Russia.

Aynur Alieva (A)

Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.

Tatiana Nagornova (T)

Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.

Anna Orlova (A)

Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.

Natalya Ogorodova (N)

Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.

Olga Shchagina (O)

Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.

Alexander Polyakov (A)

Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.

Elena Dadali (E)

Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.

Sergey Kutsev (S)

Research Centre for Medical Genetics, Moskvorechye St., 1, 115522 Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH